Surgical Laser wins and loses on patent appeal:
This article was originally published in Clinica
Surgical Laser Technologies has had one of the decisions in its three-year patent battle with Trimedyne upheld on appeal, while another decision has been reversed and sent back to a lower court for a hearing. The Montgomeryville, Pennsylvania-based Surgical Laser's contact laser tip technology has been cleared of infringing Irvine, California-based Trimedyne's hot metal tip patent. Surgical Laser is playing down the fact that its side-firing free beam probe could infringe another Trimedyne patent, saying that it is only used on one urology instrument and urology is now less important to the company.
You may also be interested in...
A regulatory framework that encourages physicians to conduct experimental cell and gene therapies have propelled China to become a major developer of such promising cancer-treating tools, but insiders say three are a plethora issues at stake.
The first of around 260 patients for a clinical trial comparing its PB006 natalizumab biosimilar candidate to Biogen’s Tysabri reference brand have been recruited by Polpharma Biologics, which has just added Karsten Roth and Alexandra Moulson to its team.